DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Industry in UK - Porter's Five Forces Strategy Analysis" report has been added to ResearchAndMarkets.com's offering.
The pharmaceutical industry in the UK has been witnessing a decline in recent years, even though the UK is home to many of the world's leading pharma companies such as GSK and AstraZeneca. The UK has one of the biggest Research and Development expenditure amongst any European nation.
The publisher analyzes the Pharmaceutical Industry in UK in the Michael Porter's Five Forces Analysis. It uses concepts developed in Industrial Organization (IO) economics to derive five forces that determine the competitive intensity and therefore attractiveness of a market. Porter referred to these forces as the microenvironment, to contrast it with the more general term macroenvironment. They consist of those forces close to a company that affect its ability to serve its customers and make a profit. A change in any of the forces normally requires a company to re-assess the marketplace.
Companies Mentioned:
- GSK
- AstraZeneca
Key Topics Covered:
A. Executive Summary
B. Introduction to the Industry
C. Porter's Five Forces Strategy Analysis
D. Conclusion
E. Glossary of Terms
For more information about this report visit https://www.researchandmarkets.com/research/xl4wcv/united_kingdom?w=4
